
Bayer Pulls Essure Birth Control Implants, Faces 16,000 Essure Lawsuits
Share |
|
Bayer announced today that it will stop selling its Essure birth control device in the United States. The device has been plagued by reports of serious side effects, with thousands of women reporting problems to the FDA. The FDA has received more than 26,000 adverse event reports and the company faces more than 16,000 lawsuits from women alleging injuries from the Essure implant.
The injury reports have brought light to serious complications associated with the Essure device, including instances where the device became dislodged or broken and migrated to other organs in the body.
While Bayer blames its woes on "inaccurate and misleading publicity about the device," more than 36,000 women have joined a private Facebook group called Essure Problems where they share stories regarding their medical ordeals.
What You Should Do
If you have experienced serious side effects associated with the Essure birth control device, promptly consult your physician for an evaluation.
If you have suffered a perforation of the uterus or fallopian tubes, or migration of the device into the abdomen or pelvic cavity, you may be entitled to compensation. You should act immediately to contact an attorney experienced in matters involving defective medical devices.
If you or a loved one has been harmed by the Essure device, please contact us for a free consultation to discuss your legal rights. You can call us toll-free at 800.883.8888 or complete our online contact form.
Essure Lawsuit News
Bayer Pulls Essure Birth Control Implants, Faces 16,000 Essure Lawsuits
Bayer announced that it will stop selling its Essure birth control device, which has been plagued by reports of serious side effects.Essure Side Effects Prompt FDA to Restrict Sales
The FDA issued an order restricting the sale and distribution of Essure implants, a response to reports that side effects attributed to the device pose a risk to women.FDA Hits Bayer's Essure Implant with Black Box Warning
The FDA announced it will require a black box warning for Essure, an implantable and permanent birth control device.